Sino Biopharmaceutical Buys Back Shares

Sino Biopharmaceutical (HK:1177) has released an update.

Sino Biopharmaceutical Limited has announced the purchase of 8 million shares on October 3, 2024, under its restricted share award scheme, representing about 0.043% of the total shares issued at an average price of HK$3.81 per share. With a total expenditure of approximately HK$30.5 million, the board retains discretion over the number of shares to be awarded and further market purchases under the scheme.

For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.